These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 18669895

  • 1. Synergistic effect of an endothelin type A receptor antagonist, S-0139, with rtPA on the neuroprotection after embolic stroke.
    Zhang RL, Zhang C, Zhang L, Roberts C, Lu M, Kapke A, Cui Y, Ninomiya M, Nagafuji T, Albala B, Zhang ZG, Chopp M.
    Stroke; 2008 Oct; 39(10):2830-6. PubMed ID: 18669895
    [Abstract] [Full Text] [Related]

  • 2. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
    Matsuo Y, Mihara Si, Ninomiya M, Fujimoto M.
    Stroke; 2001 Sep; 32(9):2143-8. PubMed ID: 11546909
    [Abstract] [Full Text] [Related]

  • 3. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience.
    Aronowski J, Strong R, Shirzadi A, Grotta JC.
    Stroke; 2003 May; 34(5):1246-51. PubMed ID: 12690223
    [Abstract] [Full Text] [Related]

  • 4. Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats.
    Shehadah A, Chen J, Cui Y, Zhang L, Roberts C, Lu M, Chopp M.
    J Neurol Sci; 2011 Oct 15; 309(1-2):96-101. PubMed ID: 21802695
    [Abstract] [Full Text] [Related]

  • 5. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
    Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Oka S, Namioka T, Namioka A, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Mikami T, Wanibuchi M, Kocsis JD, Honmou O.
    J Neurosurg; 2017 Oct 15; 127(4):917-926. PubMed ID: 28059661
    [Abstract] [Full Text] [Related]

  • 6. Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function.
    Gautier S, Petrault O, Gele P, Laprais M, Bastide M, Bauters A, Deplanque D, Jude B, Caron J, Bordet R.
    Stroke; 2003 Dec 15; 34(12):2975-9. PubMed ID: 14615621
    [Abstract] [Full Text] [Related]

  • 7. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
    Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH.
    Stroke; 2002 Aug 15; 33(8):2100-4. PubMed ID: 12154270
    [Abstract] [Full Text] [Related]

  • 8. MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.
    Ding G, Zhang Z, Chopp M, Li L, Zhang L, Li Q, Wei M, Jiang Q.
    Neuroscience; 2014 Jun 20; 271():1-8. PubMed ID: 24769225
    [Abstract] [Full Text] [Related]

  • 9. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
    Morris DC, Zhang L, Zhang ZG, Lu M, Berens KL, Brown PM, Chopp M.
    Stroke; 2001 Nov 20; 32(11):2635-40. PubMed ID: 11692028
    [Abstract] [Full Text] [Related]

  • 10. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T, Rosenberg GA.
    Stroke; 2003 Aug 20; 34(8):2025-30. PubMed ID: 12855824
    [Abstract] [Full Text] [Related]

  • 11. Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
    Zhang L, Zhang ZG, Zhang RL, Lu M, Adams J, Elliott PJ, Chopp M.
    Stroke; 2001 Dec 01; 32(12):2926-31. PubMed ID: 11739997
    [Abstract] [Full Text] [Related]

  • 12. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
    Zhang L, Zhang ZG, Zhang C, Zhang RL, Chopp M.
    Stroke; 2004 Dec 01; 35(12):2890-5. PubMed ID: 15514182
    [Abstract] [Full Text] [Related]

  • 13. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion.
    Zhang ZG, Zhang L, Tsang W, Goussev A, Powers C, Ho KL, Morris D, Smyth SS, Coller BS, Chopp M.
    Brain Res; 2001 Sep 07; 912(2):181-94. PubMed ID: 11532435
    [Abstract] [Full Text] [Related]

  • 14. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
    Zhang L, Zhang ZG, Zhang RL, Lu M, Krams M, Chopp M.
    Stroke; 2003 Jul 07; 34(7):1790-5. PubMed ID: 12805500
    [Abstract] [Full Text] [Related]

  • 15. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.
    Yang X, Chu H, Tang Y, Dong Q.
    Neuroscience; 2016 Aug 04; 329():54-65. PubMed ID: 27138645
    [Abstract] [Full Text] [Related]

  • 16. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
    Wang W, Li M, Wang Y, Li Q, Deng G, Wan J, Yang Q, Chen Q, Wang J.
    Mol Neurobiol; 2016 Dec 04; 53(10):7028-7036. PubMed ID: 26671619
    [Abstract] [Full Text] [Related]

  • 17. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
    Song HY, Chung JI, Jalin AMA, Ju C, Pahk K, Joung C, Lee S, Jin S, Kim BS, Lee KS, Ryu JM, Kim WK.
    Int J Mol Sci; 2022 Jan 26; 23(3):. PubMed ID: 35163322
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO, Arroja MM, Rocha JP, Fernandes AM, Barateiro AP, Brites DM, Pinto RM, Sepodes BM, Mota-Filipe HD.
    J Neurosurg; 2014 Jul 26; 121(1):55-62. PubMed ID: 24702327
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L, Zhang ZG, Zhang R, Morris D, Lu M, Coller BS, Chopp M.
    Circulation; 2003 Jun 10; 107(22):2837-43. PubMed ID: 12756151
    [Abstract] [Full Text] [Related]

  • 20. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
    Alonso de Leciñana M, Gutiérrez M, Roda JM, Carceller F, Díez-Tejedor E.
    J Neurol Sci; 2006 Sep 25; 247(2):121-9. PubMed ID: 16797595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.